Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Souris anti-Humain IgA1 Anticorps (PE)

ELISA Monoclonal B3506B4 IgG1 PE
N° du produit ABIN376571
  • Antigène Tous les produits IgA1
    IgA1
    Reactivité
    Humain
    Hôte
    • 7
    • 2
    • 2
    Souris
    Clonalité
    • 9
    • 2
    Monoclonal
    Conjugué
    • 4
    • 3
    • 2
    • 1
    • 1
    PE
    Application
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    ELISA
    Specificité
    Human IgA1 Fc, Mr 170 kDa
    Attributs du produit
    Mouse Anti-Human IgA1-PE
    Purification
    Purified
    Immunogène
    Fc fragment of human IgA1 myeloma protein
    Clone
    B3506B4
    Isotype
    IgG1
  • Indications d'application
    • Applications: ELISA - Quality tested , FLISA - Quality tested ELISPOT - Reported in literature , FC - Reported in literature , IHC-FS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , Multiplex - Reported in literature , Sep - Reported in literature , Depletion - Reported in literature
    • Working Dilutions: ELISA AP conjugate 1:1,000 - 1:4,000 HRP conjugate 1:1,000 - 1:4,000 BIOT conjugate 1:5,000 - 1:10,000 FLISA FITC and AF488 conjugates 1:200 - 1:400 PE and AF647 conjugates ≤ 1 g/mL
    Restrictions
    For Research Use only
  • Concentration
    0.1 mg/mL
    Buffer
    0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Do not freeze!
    Protect conjugated products from light.

    Each reagent is stable for the period shown on the bottle label if stored as directed.
    Stock
    4 °C
    Stockage commentaire
    Store at 2-8°C
  • Violari, Cotton, Kuhn, Schramm, Paximadis, Loubser, Shalekoff, Da Costa Dias, Otwombe, Liberty, McIntyre, Babiker, Gibb, Tiemessen: "A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation." dans: Nature communications, Vol. 10, Issue 1, pp. 412, (2019) (PubMed).

  • Antigène
    IgA1
    Abstract
    IgA1 Produits
Vous êtes ici:
Support technique